Towarzystwo Funduszy Inwestycyjnych PZU SA’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-105
Closed -$5.33K 708
2026
Q1
$5.33K Sell
105
-110
-51% -$5.13K ﹤0.01% 665
2025
Q4
$6.34K Hold
215
﹤0.01% 661
2025
Q3
$5.55K Hold
215
﹤0.01% 638
2025
Q2
$5.93K Sell
215
-1,150
-84% -$30.3K ﹤0.01% 632
2025
Q1
$38.7K Buy
1,365
+100
+8% +$3.55K 0.01% 460
2024
Q4
$52.6K Hold
1,265
0.02% 350
2024
Q3
$84.5K Sell
1,265
-1,850
-59% -$170K 0.03% 232
2024
Q2
$370K Hold
3,115
0.14% 63
2024
Q1
$332K Buy
3,115
+200
+7% +$20.2K 0.14% 67
2023
Q4
$290K Buy
+2,915
New +$245K 0.13% 69
2021
Q3
$743K Buy
1,930
+550
+40% +$203K 0.89% 23
2021
Q2
$324K Buy
1,380
+120
+10% +$21.4K 0.38% 38
2021
Q1
$165K Hold
1,260
0.24% 61
2020
Q4
$132K Buy
+1,260
New +$127K 0.14% 59

Other funds holding MRNA

Towarzystwo Funduszy Inwestycyjnych PZU SA's MRNA Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA sold out of Moderna (MRNA) in Q2 2026, closing a stake of 105 shares — an estimated $5.33K sold.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in MRNA in Q4 2020 and held it in 14 quarters. The position peaked at $743K in Q3 2021. 542 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 105 Moderna shares in Q2 2026, an estimated $5.33K.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Moderna in Q4 2020 and held it in 14 quarters.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Moderna position peaked at $743K in Q3 2021.
  • 542 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.